Superworth

Avantor EV/EBIT AVTR

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2020.

Today, Nov 2, 2026
28.2×
7-year median
24.0×
Against its 7-year history
76th
percentile: 0 is its lowest day, 100 its highest
7-year range
10.4× to 34.2×
Peer median
34.0×

Avantor's EV/EBIT is 28.2× as of Nov 2, 2026.

That is above its 7-year median of 24.0×, higher than on 76% of days in the last 7 years.

Over that time it ranged from 10.4× in Jan 2026 to 34.2× in Feb 2021.

The median for 10 diagnostics and research stocks of a similar size is 34.0×.

EV/EBIT over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far28.2×10.4×30.5×
202510.8×10.4×28.3×
202427.5×21.1×31.5×
202322.0×17.0×22.1×
202217.6×16.5×27.4×
202130.1×27.6×34.2×
202032.0×25.0×32.0×

Against its peers

Companies in Medical - Diagnostics & Research nearest Avantor's size, closest first, today.

CompanyEV/EBIT
AVTRAvantor28.2×
BIOBio-Rad Laboratories39.7×
CAICaris Life Sciences56.6×
RVTYRevvity44.2×
LNTHLantheus20.8×
MEDPMedpace30.4×
BLLNBillionToOne110×
CDNACareDx37.7×
DGXQuest Diagnostics19.0×
VCYTVeracyte27.9×
LHLabcorp22.9×
Peer median34.0×

Where Avantor ranks

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Avantor

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.